Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.

by Casey R Dorr, Barry I Freedman, Pamela J Hicks, W Mark Brown, Gregory B Russell, Bruce A Julian, Stephen O Pastan, Michael D Gautreaux, Amutha Muthusamy, Srinath Chinnakotla, Vera Hauptfeld, Robert A Bray, Allan D Kirk, Jasmin Divers, Ajay K Israni
Published 2016-01-01

Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes

by Michael E. Seifert, MD, MSCI, Gaurav Agarwal, MD, Miriam Bernard, BS, Ellen Kasik, BS, S. Sikandar Raza, BS, Huma Fatima, MD, Robert S. Gaston, MD, Vera Hauptfeld-Dolejsek, PhD, Bruce A. Julian, MD, Clifton E. Kew, MD, Vineeta Kumar, MD, Shikha Mehta, MD, Song Ong, MD, Frida Rosenblum, MD, Graham Towns, MD, Roslyn B. Mannon, MD
Published 2021-02-01